Mapi Research Trust selected as exclusive distributor and Mapi Language Services selected as exclusive translator of the Disability Assessment for Dementia (DAD) – Click to read full press release: https://mapigroup.com/?p=10477
Mapi Group’s Xavier Fournie, MD – Corporate Medical Director, Executive Vice-President, Global Medical Affairs – Real World Evidence will hold the role of Rapporteur for Breakout Session #1 – Emerging options: Quality Data Generation / Pan-European disease & product registries to address needs of all stakeholders on Day 2 – Thursday, 23 February 2017 from 09.00 – 11.00 am.
February 2017 Press Release: Mapi appoints Dr. Margaret (Meg) Richards to Vice President, Data Analytics and Epidemiology – Read Now!
Join Mapi’s expert roundtable on the value of early engagement with regulatory, payer, HTA, and industry perspectives. Experts from across the industry will provide an overview of European and US…
Press Release, May 2016: Mapi Research Trust/Lyon, FR — The Annual Meeting of the American Society of Clinical PsychoPharmacology (ASCP – Formerly ECDEU & NCDEU) >> Click here to read Mapi Research Trust’s full-page press release article on The Annual Meeting of the American Society of Clinical PsychoPharmacology (ASCP, formerly ECDEU and NCDEU), which MRT experts will present 2 detailed posts at in July 2016 – Arizona, USA.
Mapi Group Press Release
LYON, France, April. 2016 /PRNewswire/ — Mapi, the original developer of Linguistic Validation and most trusted provider of medical translation, has achieved ISO/IEC 17100 certification. This certification demonstrates Mapi’s commitment to transparency,…
Mapi Research Trust selected to distribute electronic versions of QOL Technologies Questionnaires
Mapi Press Release: Mapi Research Trust collaborates with CRF Health to include eCOA solutions on PROQOLID